Insider Buying Activity Uncovered - 7 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Bezos and Gates Invest in Search for Tech's Best-Kept Secret]( [Investor Alert: Discover a company flying-under-the-radar at the forefront of this megatrend.]( --------------------------------------------------------------- March 28, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Breaking: Uncle Sam Must Secure "The Seeds of Technology"]( Earth Elements are a group of metals crucial for semiconductor chips, renewable energy, electric vehicles, and MUCH more. The problem is China accounts for 70% of global mine production of them. For the U.S. and Canada, it has become a matter of national security. [Learn more about this mega trend and one company hoping to meet demand.]( --------------------------------------------------------------- [ARS Pharmaceuticals, Inc.]( Ticker: [SPRY]( Recent Price: $11.20 Average Analyst Price Target: $19.00 (69.64%) Market Cap: $1.08B Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 1,186,554 $13,289,410 2 Days Ago Recent Analyst Action: Roanna Ruiz, analyst at Leerink Partners, reiterates coverage on [ARS Pharmaceuticals, Inc. (SPRY)]( in the Healthcare sector with a Buy rating and a price target of $19 (1 week ago). Here are 3rd party ratings for [SPRY](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 36% (90 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Summit Therapeutics Inc.]( Ticker: [SMMT]( Recent Price: $4.37 Average Analyst Price Target: $8.00 (83.07%) Market Cap: $3.06B Role Transaction Description No. of Shares Amount Date CEO, Director Informative Buy Non Open Market Buy 94,071 $411,094 2 Days Ago CFO Informative Buy Non Open Market Buy 85,812 $375,000 2 Days Ago Recent Analyst Action: Bradley Canino, analyst at Stifel Nicolaus, reiterates coverage on [Summit Therapeutics Inc. (SMMT)]( in the Healthcare sector with a Buy rating and a price target of $8 (2 days ago). Here are 3rd party ratings for [SMMT](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 36% (90 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Reddit, Inc.]( Ticker: [RDDT]( Recent Price: $53.48 Average Analyst Price Target: $54.00 (0.97%) Market Cap: $8.50B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 6,357 $340,000 2 Days Ago Director Informative Buy Non Open Market Buy 1,907 $102,000 2 Days Ago Recent Analyst Action: Daniel Salmon, analyst at New Street, reiterates coverage on [Reddit, Inc. (RDDT)]( in the Communication Services sector with a Hold rating and a price target of $54 (2 days ago). Here are 3rd party ratings for [RDDT](: - TipRanks.com: Hold - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [China's Secret Plan to Bankrupt Millions of Americans?]( A mountain of evidence compiled over the past 20 months makes it clear to us that China has put in a covert plan that will cost the U.S. government $9 trillion...and harm ordinary citizens. How you handle this situation will be one of the most important financial decisions you ever make. [Get the details here]( --------------------------------------------------------------- [Herbalife Nutrition Ltd.]( Ticker: [HLF]( Recent Price: $9.89 Average Analyst Price Target: $12.50 (26.39%) Market Cap: $981.70M Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 15,282 $151,143 2 Days Ago Director Informative Buy Non Open Market Buy 5,067 $50,121 2 Days Ago Recent Analyst Action: Linda Bolton, analyst at D.A. Davidson, reiterates coverage on [Herbalife Nutrition Ltd. (HLF)]( in the Consumer Defensive sector with a Hold rating and a price target of $9.5 (2 days ago). Here are 3rd party ratings for [HLF](: - TipRanks.com: Hold - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 8% (232 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Mirum Pharmaceuticals, Inc.]( Ticker: [MIRM]( Recent Price: $25.36 Average Analyst Price Target: $49.40 (94.79%) Market Cap: $1.18B Role Transaction Description No. of Shares Amount Date CFO Informative Buy Non Open Market Buy 1,955 $49,600 2 Days Ago Recent Analyst Action: Mani Foroohar, analyst at Leerink Partners, reiterates coverage on [Mirum Pharmaceuticals, Inc. (MIRM)]( in the Healthcare sector with a Buy rating and a price target of $43 (1 week ago). Here are 3rd party ratings for [MIRM](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 32% (80 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [2024 Could be Your Last Chance to Ever Get Rich From Crypto]( Shrem, who bought Bitcoin at $5 back in 2011, warns that 2024 could be your very last opportunity to create generational wealth from crypto. After a new government regulation set to inject $30 trillion into the crypto markets, we're likely to never see buy-in prices this low ever again. He details everything you need to take advantage of this huge, and final crypto bull run in his emergency presentation. [Click here to discover his top 5 coins for 2024]( --------------------------------------------------------------- [ImmunoPrecise Antibodies Ltd.]( Ticker: [IPA]( Recent Price: $1.59 Average Analyst Price Target: $9.00 (466.04%) Market Cap: $41.84M Role Transaction Description No. of Shares Amount Date Interim Chief Financial Officer Informative Buy Buy 5,000 $7,650 2 Days Ago President & CEO Informative Buy Buy 3,000 $4,470 3 Days Ago Recent Analyst Action: Swayampakula Ramakanth, analyst at H.C. Wainwright, reiterates coverage on [ImmunoPrecise Antibodies Ltd. (IPA)]( in the Healthcare sector with a Buy rating and a price target of $9 (1 week ago). Here are 3rd party ratings for [IPA](: - TipRanks.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 34% (86 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Zevia PBC]( Ticker: [ZVIA]( Recent Price: $1.08 Average Analyst Price Target: $3.75 (247.22%) Market Cap: $77.60M Role Transaction Description No. of Shares Amount Date SVP, GC & Corporate Secretary Informative Buy Non Open Market Buy 4,930 $5,325 2 Days Ago Recent Analyst Action: Alton Stump, analyst at Loop Capital Markets, reiterates coverage on [Zevia PBC (ZVIA)]( in the Consumer Defensive sector with a Buy rating and a price target of $4 (1 month ago). Here are 3rd party ratings for [ZVIA](: - TipRanks.com: Hold - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 35% (89 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Big Pharma's Worst Nightmare Could Make You Rich]( tiny firm’s patented “smart cell” technology could turn the drug industry upside down. [Click here now for details.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com 1519 Mecklenburg Hwy Unit 4 | Mt. Mourne | NC | 28123 | United States | 877 411 9808 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software